Parvimonas micra

Oral Commensal-to-Pathobiont Transition#

P. micra is a normal inhabitant of the oral cavity, found in dental plaque, periodontal pockets, and the tongue dorsum in most healthy humans. In oral health, it occupies a minor ecological niche, antagonized by more dominant oral species (e.g., Streptococcus mutans, Prevotella intermedia).

However, under conditions of periodontal disease, poor oral hygiene, or Dysbiosis. P. micra increases in abundance within oral biofilms (10-fold expansion in periodontitis). Produces proteases and lipopolysaccharides (LPS) that damage periodontal tissues.

Translocates to the colon via a two-stage pathway.

Intestinal dysbiosis (reduced Butyrate, increased Metal-Driven Inflammation) compromises barrier integrity → increased gut permeability. Bloodstream translocation through the leaky epithelium; then reseeding into the colon via fecal circulation or direct recolonization.

Epidemiologically, patients with severe periodontitis have 2–3× higher CRC risk, supporting the oral-colorectal carcinoma axis hypothesis.

Iron Acquisition via Siderophores#

P. micra is iron-dependent and produces catecholate-type siderophores to scavenge iron in the low-iron colonic environment.

Siderophore synthesis: Encodes genes for dihydroxybenzoic acid (DHBA) biosynthesis and iron-catecholate receptors. Mechanism: Secreted siderophores form tight iron(III) (Fe3+) complexes; the iron-siderophore complex is transported back via TonB-dependent receptors (similar to enterobactin piracy in E. coli).

Competitive effect: P. micra siderophores compete with host hepcidin-controlled iron, driving a local iron-scavenging microenvironment that advantages other iron-dependent pathogens (Fusobacterium, Bacteroides fragilis) while suppressing iron-sensitive commensals.

Direct Epithelial Invasion and Inflammation#

P. micra adheres directly to colonocyte apical surface via Type IV pili. Lipoteichoic acid (LTA) → TLR2 signaling → NF-κB activation → IL-6, IL-8, IL-1β production. Localized Th17 polarization (IL-17-producing CD4+ T cells) → further inflammation → epithelial damage.

Repeated cycles of adhesion, damage, and immune activation → chronic epithelial barrier compromise.

Integration with Colibactin and other Genotoxins#

Does not produce colibactin itself, but biofilm-integrated Peptostreptococcus stomatis (pks+) and Escherichia coli (pks+) strains do. P. micra biofilm acts as a delivery system for colibactin-producing partners, enabling direct epithelial contact with genotoxins. Colibactin → double-strand breaks in colonocytes → p53 activation, aberrant crypt formation, dysplasia.

Iron Dysbiosis and Functional Anemia#

P. micra iron siderophore production → local iron scarcity. Host responds with hepcidin elevation (systemic iron-withholding defense). Iron-dependent Faecalibacterium prausnitzii and butyrate producers → suppressed.

Iron-dependent pathogens (P. micra, Fusobacterium, Bacteroides fragilis) → enriched. Result: Functional iron anemia (low hepcidin paradoxically present with high circulating iron in heme/enterocyte-bound forms) drives CRC risk.

CRC-Specific Enrichment#

P. micra is one of the few taxa with CRC-specificity comparable to advanced cancer biomarkers.

Sensitivity: Detected in 70–95% of CRC cases (depending on polymerase chain reaction vs culture method). Specificity: Rare in healthy controls (<5% abundance); minimal in adenoma-only patients. Independence from screening method: Enriched in both 16S rRNA studies and metagenomics; independent biomarker strength despite methodological differences.

Cross-population consistency: Found in CRC cohorts across North America, Europe, Asia, and Africa.

Clinical Relevance#

Early CRC biomarker: Already enriched in advanced adenomas (AJCC stage III-IV); could enable early detection. Stage-independent: Abundance does not strongly correlate with TNM stage, suggesting P. micra enables adenoma-to-carcinoma transition rather than promoting late-stage progression.

Prognostic value: Emerging evidence suggests P. micra burden may correlate with poor prognosis and reduced response to immunotherapy.

Culture-Based Methods#

Anaerobic culture: Grows on Brucella agar + blood under 85% N2 / 10% H2 / 5% CO2. Colony morphology: Tiny (0.5–1 mm), translucent, mucoid colonies; slower growth than Fusobacterium. 16S rRNA RFLP or sequencing: Confirms identity; distinguishes from closely related Parvimonas species.

Biofilm Detection#

FISH (fluorescence in situ hybridization): Directly visualize P. micra within colorectal mucosal biofilms using species-specific probes. Confocal microscopy: Reveals P. micra biofilm structure and integration with Fusobacterium and other partners.